Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy

Nobuhiro Dougu1, Shuji Joho, Lishen Shan

  • 1Department of Neurology, Toyama University Hospital, Toyama University Hospital, Toyama, Japan.

Insights

Danon disease, a genetic disorder affecting the heart and muscles, is caused by LAMP2 gene mutations. This study identifies a novel mutation in a family, highlighting the need for further functional analysis.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Danon disease is an X-linked dominant disorder impacting multiple organ systems.
  • It is characterized by hypertrophic cardiomyopathy and skeletal myopathy.
  • Mutations in the lysosome-associated membrane protein-2 (LAMP2) gene are the underlying cause, with over 20 identified to date.

Observation:

  • A family with three affected members (18-year-old male proband, 15 and 20-year-old sisters) was studied.
  • The proband exhibited concentric hypertrophy from age 5.
  • The mother had dilated cardiomyopathy and died from heart failure.

Findings:

  • DNA analysis revealed a novel hemizygous frameshift mutation (c.573delA) in exon 5 of the LAMP2 gene in the male proband.
  • The two affected sisters were heterozygous for the same LAMP2 mutation.
  • This represents a new genetic variant contributing to Danon disease.

Implications:

  • Identification of a novel LAMP2 mutation provides further insight into the genetic landscape of Danon disease.
  • Functional studies are essential to understand the pathogenicity of this specific mutation.
  • This research underscores the importance of genetic diagnostics in multisystem disorders like Danon disease.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...